Welcome
to the updated Immunization Page!
In
an effort to consolidate and organize the rapidly changing
information on vaccinations for children, this page has been
re-organized to make it easier to navigate. The main areas
may be reached by using the links on the left. Important new
links will be listed below.
AAP
District II is consolidating vaccine information so that it is not
duplicated on the Chapter web sites. If you have arrived here by
using a link from a New York Chapter web site, you may return by
clicking here or on the links to the left.
NY
State Statewide Immunization Information System (NYSIIS) (aka - Immunization Registry)
Our
overarching message is: "NYSIIS implementation roll out has
begun as planned with the statewide local health department training
underway and region specific provider training and system
access to follow according to our specified schedule."
THE PLAN IS
STILL TO BRING PROVIDERS ON BOARD OVER TIME AND REGIONALLY.
PROVIDERS ARE ENCOURAGED TO WAIT FOR THEIR REGIONAL TRAININGS/ROLL
OUT PERIOD. PROVIDERS ARE ENCOURAGED TO GET THEIR HPN ACCOUNTS SET
UP IN THE MEANTIME. Link for providers to begin HPN account process:
https://commerce.health.state.ny.us/pub.
Dr. Henry Schaeffer wants all pediatricians in New York to know that
"penalties for non-compliance will not be
issued during the implementation period, which should take a couple
of years."
Assistance
with HPN process: Commerce Account Management Unit (CAMU) Help
Desk 1-866-529-1890 or hinhpn@health.state.ny.us.
First
provider training is scheduled for Jan 15-Feb15 in the Upper Hudson
Region. Those that sign up for training will be set up with NYSIIS
accounts. For previous regional registry users, their past data may
not be available immediately after their training date. The plan is
to get all Upper Hudson data migrated by 2/15/08 and to continue
migration regionally as quickly as possible.
If a
provider really wants to get on the system before their regional
roll out, the EDS Help Desk can set up one person per organization
as the first administrative user. The EDS Help Desk is now live Mon
- Fri from 8:00am to 5:00pm. Assistance with getting a NYSIIS
account or using the actual application: EDS Help Desk
1-866-389-0371 or nysiishelpdesk@eds.com.
Early
adopting users (i.e. those before their roll out) should sign
themselves up for Webinar training ASAP. Register at: http://nysdoh.webex.com.
Open "Training Center" and click on the tab labeled
"Upcoming." Select a training session and click on
the registration icon to the far right.
Non-interactive independent learning opportunities for providers
such as on-line tutorials and system manuals will be available
after January 1, 2008. Access to the NYSIIS will be through
the Health
Provider Network (HPN), so it is important to sign up to the
network in advance.
Get
an HPN account for your organization and users
Confirm
Internet access available for designated users
Investigate
specs for data upload process. This link is to a pdf
file with the specifications
for you to give to you office management program
manufacturers.
Register
for formal training (when available) or complete independently
Begin
actively reporting no later than the implementation date for
your region.
Based
on the recommendation of the Commissioner of Health, the
(Insurance) Department has determined that covered
necessary immunizations under the law are those recommended
by the ACIP, and should the ACIP amend its recommendations,
...HMOs will take the necessary steps to provide coverage in
accordance with the ACIP revised schedule, effective as of the
date of the change.
Please direct any questions concerning
the Circular Letter to:
Deborah A. Kozemko, J.D.
Supervising Insurance Attorney
New York State Insurance Department
One Commerce Plaza
Albany, NY 12257
E-mail: dkozemko@ins.state.ny.us
Recommendations
for Influenza Vaccine, 2007-2008
The American Academy of Pediatrics
(AAP) recommends annual influenza immunization for all children
with high-risk conditions who are 6 months and older; all healthy
children ages 6 through 59 months; all household contacts and
out-of-home caregivers of children who have high-risk conditions
and/or healthy children younger than 5 years; and all health care
professionals.
The purpose of this statement is to
update the current recommendations for routine use of influenza
vaccine in children, which were originally published in a
condensed version in April 2007. New information includes (1)
harmonization of the recommendation of the AAP and the Centers for
Disease Control and Prevention that children younger than 9 years
receive two doses of influenza vaccine in their second season of
immunization if they received only one dose in the previous seaon;
and (2) further details on the administration of live-attenuated
influenza vaccine (LAIV), including the recommendation for the use
of LAIV in children as young as 2 years.
Merck & Co., Inc.
has reported that PedvaxHIB® is unavailable for shipment.
Based on the latest information, Merck expects PedvaxHIB® (PRP-OMP)
to be available sometime in the first quarter of 2008. Merck
reports that the exact timing is dependent upon resolution of a
manufacturing issue. There are currently adequate amounts of
ComVax® (PRP-OMP/Hepatitis B) to meet historical demand, but not
to meet additional demand.
Limited amounts of
PedvaxHIB® (PRP-OMP) will be made available from the CDC vaccine
stockpile. Doses for the private sector will be made
available through Merck & Co., Inc. and to the public sector
through the CDC vaccine contracts.
There will not be a
sufficient quantity of stockpile vaccine to meet the historical
demand for the PedvaxHIB® (PRP-OMP). Sanofi Pasteur is
working to provide additional ActHib® (PRP-T) to meet
demand. Current estimates are that providers of Haemophilus
influenzae b conjugate vaccine (Hib) will need to utilize ActHib®
(PRP-T) for approximately one-half of their historical PedvaxHIB®
(PRP-OMP) use for the immediate future. Orders placed beyond
the available inventory of vaccine will result in backorders.
Updates of vaccine
availability will be provided as more information becomes
available. If it becomes necessary to complete a series with
PRP—T (ActHIB® [sanofi pasteur]) that was started with PRP-OMP
(PedvaxHIB® or ComVax® (PRPOMP/Hepatitis B) [Merck]), the
following guidelines may be followed:
If the first 2
doses of PRP-OMP were administered as the primary series, any
Haemophilus influenzae b conjugate vaccine including PRP-T may
be administered for the dose 3 booster at age 12-15 months.
If only one dose
of PRP-OMP has been administered, the primary series may be
completed with 2 additional doses of PRP-T. There should be a
minimum interval of 4 weeks between all doses of the primary
series followed by a 4th dose as a booster at age 12-15
months.
